X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (160) 160
Book Review (6) 6
Conference Proceeding (6) 6
Patent (5) 5
Publication (2) 2
Book Chapter (1) 1
Data Set (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (91) 91
index medicus (88) 88
female (52) 52
male (50) 50
middle aged (44) 44
oncology (43) 43
melanoma (41) 41
aged (35) 35
dermatology (35) 35
adult (34) 34
melanoma - drug therapy (34) 34
melanoma - pathology (28) 28
cancer (25) 25
skin neoplasms - drug therapy (24) 24
skin neoplasms - pathology (23) 23
malignant-melanoma (20) 20
aged, 80 and over (18) 18
care and treatment (15) 15
melanoma - secondary (15) 15
treatment outcome (15) 15
metastasis (14) 14
metastatic melanoma (13) 13
cell biology (12) 12
neoplasm staging (12) 12
antineoplastic agents - therapeutic use (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
dacarbazine (11) 11
medicine, research & experimental (11) 11
tumors (11) 11
melanoma - immunology (10) 10
melanoma - mortality (10) 10
biochemistry (9) 9
chemotherapy (9) 9
melanoma - diagnosis (9) 9
melanoma - therapy (9) 9
molecular biology (9) 9
antigen (8) 8
dacarbazine - administration & dosage (8) 8
further section (8) 8
immunology (8) 8
immunotherapy (8) 8
melanoma - metabolism (8) 8
mice (8) 8
mutation (8) 8
neoplasm metastasis (8) 8
skin (8) 8
skin neoplasms - diagnosis (8) 8
skin neoplasms - mortality (8) 8
survival (8) 8
young adult (8) 8
adolescent (7) 7
analysis (7) 7
animals (7) 7
biochemistry & molecular biology (7) 7
cell line, tumor (7) 7
clinical trials (7) 7
cytokines (7) 7
disease progression (7) 7
kaplan-meier estimate (7) 7
melanoma - genetics (7) 7
metastases (7) 7
prognosis (7) 7
proto-oncogene proteins b-raf - genetics (7) 7
skin cancer (7) 7
skin neoplasms - therapy (7) 7
time factors (7) 7
antineoplastic agents - adverse effects (6) 6
disease-free survival (6) 6
expression (6) 6
follow-up studies (6) 6
hematology, oncology and palliative medicine (6) 6
identification (6) 6
immunohistochemistry (6) 6
interferon-alpha - administration & dosage (6) 6
monoclonal-antibody (6) 6
rna, messenger - genetics (6) 6
skin neoplasms - immunology (6) 6
therapy (6) 6
antineoplastic agents - administration & dosage (5) 5
basic electric elements (5) 5
carcinoma (5) 5
cells, cultured (5) 5
cutaneous melanoma (5) 5
dendritic cells (5) 5
electric solid state devices not otherwise provided for (5) 5
electricity (5) 5
flow cytometry (5) 5
induction (5) 5
interferon-alpha (5) 5
keratinocytes (5) 5
lymphocytes (5) 5
management (5) 5
melanoma - blood (5) 5
melanoma - complications (5) 5
mutations (5) 5
open-label (5) 5
patients (5) 5
prospective studies (5) 5
recombinant proteins (5) 5
resistance (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 11, pp. 1087 - 1095
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 6, pp. 716 - 728
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 2, pp. 107 - 114
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2013, Volume 31, Issue 5, pp. 616 - 622
Journal Article
Cancer Discovery, ISSN 2159-8274, 01/2014, Volume 4, Issue 1, pp. 94 - 109
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, pp. e53745 - e53745
Background: Ipilimumab, a cytotoxic T-lymphocyte antigen-4 (CTLA-4) blocking antibody, has been approved for the treatment of metastatic melanoma and induces... 
TRIAL | CTLA-4 BLOCKADE | INDUCED SARCOIDOSIS | LYMPHOCYTE-ASSOCIATED ANTIGEN-4 | AUTOIMMUNE-DISEASES | PHASE-I/II | MULTIDISCIPLINARY SCIENCES | TREMELIMUMAB CP-675,206 | MONOCLONAL-ANTIBODY | PATIENT | CANCER | Skin Neoplasms - drug therapy | Humans | Ipilimumab | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Neoplasm Metastasis | Liver - drug effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Endocrine System - drug effects | Adult | Female | Retrospective Studies | Antibodies, Monoclonal - immunology | Kidney - drug effects | Antineoplastic Agents - immunology | Pancreas - drug effects | Gastrointestinal Tract - drug effects | Melanoma - pathology | CTLA-4 Antigen - immunology | Nervous System - drug effects | Melanoma - drug therapy | Respiratory System - drug effects | Aged | Skin - drug effects | Antimitotic agents | Antigens | Care and treatment | Algorithms | Lymphocytes | Melanoma | Skin | Metastasis | Antineoplastic agents | Skin cancer | Cancer | Aseptic meningitis | Guillain-Barre syndrome | Exanthema | Central nervous system | Blocking antibodies | Cytotoxicity | Oncology | Lymphocytes T | Metastases | CTLA-4 protein | Intestine | Gastroenterology | Meningitis | Internal medicine | Hematology | Sarcoidosis | Dermatology | Management | Regression analysis | Patients | Eosinophilia | Morbidity | Inflammatory bowel disease | Pathology | Side effects | Hospitals | Perforations | Medical prognosis | Antitumor activity | Autoimmune diseases | Endocrinology | Index Medicus
Journal Article
Skin Research and Technology, ISSN 0909-752X, 05/2013, Volume 19, Issue 2, pp. 75 - 83
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2016, Volume 75, Issue 1, pp. 113 - 125.e5